Related Experiment Video
Updated: Nov 14, 2025

06:26
Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
616
Balloon aortic valvuloplasty through the novel transradial technique
Horacio A Medina DE Chazal1, Ignacio M Seropian2, Francisco Romeo3
1Department of Interventional Cardiology, Italian Hospital of Buenos Aires, Buenos Aires, Argentina - horacio.medina@hospitalitaliano.org.ar.
Minerva Cardiology and Angiology
|March 11, 2021
Summary
Transradial aortic valve valvuloplasty (TRBAV) offers a safe and effective alternative to traditional femoral approaches for balloon aortic valvuloplasty. This novel technique demonstrates feasibility with low complication rates, including radial artery occlusion.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Vascular Access Techniques
Background:
- Traditional femoral access for balloon aortic valvuloplasty (BAV) is associated with increased risks of bleeding and vascular complications.
- Exploring alternative access routes is crucial for improving patient safety and procedural outcomes in BAV.
Purpose of the Study:
- To evaluate the safety and efficacy of transradial aortic valve valvuloplasty (TRBAV).
- To assess procedural success rates and complication profiles associated with the transradial approach for BAV.
Main Methods:
- Retrospective, single-center study of patients undergoing TRBAV between October 2019 and July 2020.
- BAV performed using 18-25 mm balloons via 8-10 French radial sheaths.
- Success defined as ≥50% reduction in peak-to-peak aortic gradient; safety assessed via procedural complications and radial artery occlusion (RAO).
Main Results:
- Ninety-one percent (91%) of the 24 patients achieved successful BAV, with a significant reduction in mean aortic valve gradient (50±24 mmHg pre- to 18.7±13 mmHg post-procedure).
- The procedure utilized predominantly 8F and 9F sheaths for 20 mm and 23 mm balloons.
- Low complication rates observed: no major procedural complications, no access-site bleeding, and asymptomatic RAO in 8% of patients (2/24).
Conclusions:
- Transradial aortic valve valvuloplasty (TRBAV) is a safe, feasible, and effective alternative to femoral access for selected patients.
- The technique demonstrates reproducibility with a low rate of conversion and radial artery occlusion.
- Larger studies are warranted to further confirm the utility of TRBAV.

